Molecular identification of the ompL1 gene within Leptospira interrogans standard serovars

Mehrangiz Dezhbord1, Majid Esmaelizad, Pejvak Khaki

  • 1Razi Vaccine and Serum Research Institute, Karaj, Iran. asal_dejbord@yahoo.com.

Abstract

Insights

A conserved OmpL1 gene was identified in pathogenic Leptospira strains, showing minimal variation. This finding supports the development of a recombinant OmpL1 vaccine for leptospirosis control.

Area of Science:

  • Veterinary Microbiology
  • Infectious Diseases
  • Vaccine Development

Background:

  • Leptospirosis is a widespread zoonotic disease globally.
  • Current vaccines use dead whole-cell mixtures of limited serovars.
  • Developing an efficient recombinant vaccine is crucial for leptospirosis control.

Purpose of the Study:

  • To analyze the ompL1 gene in pathogenic Leptospira strains.
  • To investigate the potential of OmpL1 as a conserved vaccine antigen.

Main Methods:

  • PCR amplification and cloning of the ompL1 gene from three pathogenic L. interrogans strains.
  • Sequencing and phylogenetic analysis of the ompL1 gene and OmpL1 protein.

Main Results:

  • A 963 bp ompL1 gene product was successfully amplified.
  • The ompL1 gene detected all tested pathogenic Leptospira serovars.
  • OmpL1 nucleotide sequences showed 85%-100% identity, with minimal amino acid differences.

Conclusions:

  • The ompL1 gene is highly conserved among the studied Leptospira isolates.
  • Recombinant OmpL1 holds promise as an effective and conserved antigen for a leptospirosis vaccine.